Table 3 Cox regression analysis for clinical outcomes in RCC patients.
From: Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma
Characteristics | HR for overall survival | HR for progression-free interval | HE for disease-specific survival |
|---|---|---|---|
Age (> 60 vs. ≤ 60) | 1.80**** | 1.33 | 1.40 |
Sex (male vs. female) | 0.93 | 1.52* | 1.22 |
Stage (stage III/IV vs. stage I/II) | 3.95**** | 6.82**** | 9.83**** |
Histological grade (grade III/IV vs. stage I/II) | 2.70**** | 3.65**** | 4.79**** |
T stage (T3–T4 vs. T1–T2) | 3.23**** | 4.52**** | 5.54**** |
N stage (N1–N2 vs. N0) | 3.45**** | 3.68**** | 3.85**** |
M stage (M1 vs. M0) | 4.39**** | 8.97**** | 9.11**** |
Smoker (yes vs. no) | 0.79 | 1.06 | 1.22 |
RAD54L2 (high vs. low) | 0.60* | 0.60* | 0.54* |
